Analytical Data
-
基因名
SLAMF2/CD48
- Application
-
别名
B-lymphocyte activation marker BLAST-1 BCM1 surface antigen Leukocyte antigen MEM-102 SLAM family member 2 Short name: SLAMF2 Signaling lymphocytic activation molecule 2 TCT.1 CD_antigen: CD48 BCM1, BLAST1
-
种属
Human
-
表达系统
Yeast
-
标签
N- hFc
-
纯度
Greater than 85% as determined by SDS-PAGE.
-
蛋白编号
P09326
-
表达区间
27-220aa
-
分子量
48.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLAMF2, also known as CD48, is a crucial member of the SLAM (Signaling Lymphocyte Activation Molecule) family of proteins, which play significant roles in immune responses and cell signaling. The CD48 protein is primarily expressed on immune cells, including T cells, B cells, and natural killer (NK) cells, and acts as a co-stimulatory molecule that influences the activation, differentiation, and function of these cells. Research on SLAMF2/CD48 has gained attention due to its involvement in various immune disorders, infectious diseases, and cancers. Understanding the structure and function of SLAMF2/CD48 is essential for developing potential therapeutic strategies, as modulation of its activity may enhance immune responses or suppress aberrant ones. The generation of recombinant SLAMF2/CD48 proteins facilitates detailed studies of its interactions with ligands and receptors, as well as its signaling pathways. This research is pivotal in elucidating the mechanisms underlying immune regulation and could lead to novel immunotherapeutic approaches for boosting antitumor immunity or treating autoimmune diseases. Thus, the study of SLAMF2/CD48 recombinant proteins not only provides insights into fundamental immunological processes but also holds promise for advancing clinical applications in immunology and oncology.
